AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9627258
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (1 mg/kg of 2% lidocaine before extubation)
Trial: 9627258
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution (used topically in the first control group)
Trial: 3276150
Drug: Oral miconazole
RxNorm normalized name: miconazole Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral miconazole
Trial: 29733445
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 70 μg/d
Trial: 26304595
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II type I receptor blocker (ARB) medication
Trial: 26304595
Drug: Increase of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increase of eUUN or protein intake during ARB treatment
Trial: 23098134
Drug: Ingesting all
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ingesting all hypertension medications upon awakening
Trial: 23098134
Drug: Ingesting ≥1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ingesting ≥1 hypertension medications at bedtime
Trial: 23098134
Drug: Ingesting all
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ingesting all hypertension medications at bedtime
Trial: 18315706
Drug: Bolus intravenous
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus intravenous furosemide
Trial: 18315706
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous furosemide infusion
Trial: 12690278
Drug: Amoxicillin/clavulanate (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (25 mg/kg every 12 h)
Trial: 7685428
Drug: Casodex 50
RxNorm normalized name: Casodex 50mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casodex 50 mg daily for 24 weeks
Trial: 2404631
Drug: Colestipol plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol plus niacin therapy
Trial: 7000168
Drug: Mefenamic acid
RxNorm normalized name: Mefenamic Acid
DrugBank: Mefenamic acid (DB00784)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mefenamic acid (500 mg thrice daily)
Trial: 28697785
Drug: Aquatic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aquatic therapy program (12 weeks, aerobic and functional exercises in circuit training)
Trial: 15483801
Drug: Lateral joint
RxNorm normalized name: Joint Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lateral joint line injection
Trial: 15483801
Drug: Superomedial injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Superomedial injection
Trial: 15483801
Drug: Superolateral injection
RxNorm normalized name: TITANIUM DIOXIDE 4 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL CREAM [supernatural poreless tint spf 15]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Superolateral injection
Trial: 9044517
Drug: Intracavernous injection
RxNorm normalized name: Bivalirudin 250 mg INTRACAVERNOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernous injection of papaverine
Trial: 8172713
Drug: Casodex 50
RxNorm normalized name: Casodex 50mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casodex 50 mg once daily
Trial: 8172713
Drug: Casodex 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casodex 100 mg/day
Trial: 30087040
Drug: CDM Group-II
RxNorm normalized name: Corticosteroids, moderately potent (group II)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDM Group-II (additional interventions including early postpartum follow-up and beta-blocker therapy)
Trial: 23106760
Drug: Group drug
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group drug counseling with positive alliance with counselor
Trial: 23106760
Drug: Group drug
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group drug counseling with advice from counselor and group members
Trial: 23106760
Drug: Group drug
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group drug counseling with self-disclosure and participation
Trial: 20579938
Drug: Desmopressin (0.2-0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin (0.2-0.4 mg daily)
Trial: 29995359
Drug: Escitalopram 5-10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 5-10 mg/d
Trial: 27084692
Drug: Escitalopram 10-20
RxNorm normalized name: escitalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 10-20 mg/d
Trial: 17012890
Drug: DTPw-HepB-Hib combination
RxNorm normalized name: poliovirus vaccine inactivated, type 1 (Mahoney)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPw-HepB-Hib combination vaccine (Quinvaxem)
Trial: 17012890
Drug: DTPw-Hib and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPw-Hib and hepatitis B vaccines (comparator group)
Trial: 14609821
Drug: Umbilical cord
RxNorm normalized name: Sus Scrofa Umbilical Cord
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Umbilical cord serum therapy
Trial: 27921414
Drug: Autologous serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous serum therapy
Trial: 9220839
Drug: Unna's boot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unna's boot and activated charcoal treatment
Trial: 26667403
Drug: Intravenous dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous dexamethasone (10 mg)
Trial: 24218006
Drug: Basel cocktail
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basel cocktail (low doses of caffeine, efavirenz, losartan, omeprazole, metoprolol, midazolam)
Trial: 18310583
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy (CCBT)
Trial: 18310583
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy (CCBT) followed by mirtazapine
Trial: 15650277
Drug: PregVit p.m.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PregVit p.m. (1 tablet containing 1.1 mg of folic acid) administered in the morning
Trial: 15650277
Drug: PregVit p.m.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PregVit p.m. (1 tablet containing 1.1 mg of folic acid) administered in the evening
Trial: 15650277
Drug: PregVit p.m.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PregVit p.m. (morning administration)
Trial: 15650277
Drug: PregVit p.m.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PregVit p.m. (evening administration)
Trial: 10405497
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 0.3 mg/kg per dose
Trial: 10405497
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 0.6 mg/kg per dose
Trial: 7996065
Drug: L-asparaginase
RxNorm normalized name: L-asparaginase
DrugBank: Asparaginase Erwinia chrysanthemi (DB08886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-asparaginase
Trial: 2374231
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural anesthesia with 0.33 ml.kg.‐1 0.25% bupivacaine before surgery (group A)
Trial: 2374231
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural anesthesia with 0.33 ml.kg.‐1 0.25% bupivacaine after surgery (group B)
Trial: 6773715
Drug: tocainide 600
RxNorm normalized name: tocainide 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tocainide 600 mg three times daily for 8 weeks
Trial: 6773715
Drug: quinidine sulfate
RxNorm normalized name: Quinidine Sulfate
DrugBank: Quinidine (DB00908)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: quinidine sulfate 300 mg four times daily for 8 weeks
Trial: 6773715
Drug: placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo administered for 6 weeks
Trial: 25516371
Drug: Guanfacine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine (3 mg/day)
Trial: 27146258
Drug: Cholecalciferol 50
RxNorm normalized name: cholecalciferol 50 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 50 μg (2000 IU) daily
Trial: 27146258
Drug: Cholecalciferol 50
RxNorm normalized name: cholecalciferol 50 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 50 μg per day
Trial: 24661355
Drug: Cholecalciferol 75
RxNorm normalized name: cholecalciferol 75000 UNT/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol 75 μg (3000 IU) daily for 6 months
Trial: 18936596
Drug: Intravenous parecoxib
RxNorm normalized name: parecoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Intravenous parecoxib 40 mg followed by an additional dose of parecoxib 20 mg
Trial: 18936596
Drug: Parecoxib 20
RxNorm normalized name: parecoxib 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parecoxib 20 mg once daily
Trial: 18936596
Drug: Parecoxib 20
RxNorm normalized name: parecoxib 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parecoxib 20 mg twice daily
Trial: 1653363
Drug: Granisetron (BRL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (BRL 43694A) - single intravenous dose
Trial: 6401422
Drug: Balanced substrate
RxNorm normalized name: BISMUTH SUBCITRATE
DrugBank: Bismuth subcitrate potassium (DB09275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Balanced substrate formula (40 kcal/kg/day, 1 to 1.5 g protein/kg/day, carbohydrate-nitrogen ratio 50:1)
Trial: 6401422
Drug: 25% dextrose
RxNorm normalized name: Delflex with 4.25% Dextrose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% dextrose and 4.25% protein solution (50 kcal/kg/day, 1 to 1.5 g protein/kg/day, carbohydrate-nitrogen ratio 150:1)
Trial: 6401422
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (nonseptic patients receiving 25% dextrose and 4.25% protein solution)
Trial: 28688174
Drug: 200 mL
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mL of tomato juice (TJ)
Trial: 28688174
Drug: 400 mL
RxNorm normalized name: Lantidra 400 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mL of tomato juice (TJ)
Trial: 16972106
Drug: d-amphetamine 15
RxNorm normalized name: dextroamphetamine
DrugBank: Dextroamphetamine (DB01576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine 15 mg/70 kg
Trial: 17544491
Drug: d-amphetamine 3.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine 3.125 mg/70 kg
Trial: 16972106
Drug: d-amphetamine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine 7.5 mg/70 kg
Trial: 17544491
Drug: sublingual estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sublingual estradiol 0.25 mg
Trial: 1502481
Drug: Baker's yeast
RxNorm normalized name: Baker's yeast proteinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baker's yeast capsules
Trial: 6380447
Drug: Trazodone hydrochloride
RxNorm normalized name: Trazodone Hydrochloride
DrugBank: Trazodone (DB00656)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trazodone hydrochloride (100 mg)
Trial: 6380447
Drug: Cocaine hydrochloride
RxNorm normalized name: Cocaine Hydrochloride
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine hydrochloride (2 mg/kg)
Trial: 20555311
Drug: Modafinil (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (100 mg/day for 7 days)
Trial: 8873009
Drug: Thymosin alpha
RxNorm normalized name: Thymosin alpha 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymosin alpha 1 (900 micrograms/m2 of body surface area twice weekly)
Trial: 6732217
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg of Sch 29,482 orally every 6 h for 4 days
Trial: 30669897
Drug: Initial nonoperative
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial nonoperative treatment
Trial: 25938001
Drug: Temsirolimus 175/75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temsirolimus 175/75 mg
Trial: 19415181
Drug: Temsirolimus 75
RxNorm normalized name: Temsirolimus
DrugBank: Temsirolimus (DB06287)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Temsirolimus 75 mg
Trial: 19825908
Drug: Paliperidone extended-release
RxNorm normalized name: Paliperidone Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone extended-release 12 mg on days 1-6
Trial: 19825908
Drug: Risperidone immediate-release
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone immediate-release 2 mg on day 1 and 4 mg on days 2-6
Trial: 18043445
Drug: Pentavalent human-bovine
RxNorm normalized name: human-bovine reassortant rotavirus strain G1 vaccine / human-bovine reassortant rotavirus strain G2 vaccine / human-bovine reassortant rotavirus strain G3 vaccine / human-bovine reassortant rotavirus strain G4 vaccine / human-bovine reassortant rotavirus strain P1A[8] vaccine Oral Suspension [RotaTeq]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentavalent human-bovine (WC3) reassortant rotavirus vaccine
Trial: 3544744
Drug: Etretinate (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etretinate (10 mg capsule once a day)
Trial: 29465649
Drug: Metronidazole 750
RxNorm normalized name: metronidazole 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 750 mg + miconazole 200 mg intravaginal suppositories for 5 consecutive nights each month for 12 months
Trial: 27595688
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy without ICD
Trial: 24198342
Drug: EMG-triggered electrical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMG-triggered electrical stimulation to the four muscle groups of the affected arm plus usual therapy five times a week for four weeks
Trial: 24198342
Drug: Usual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual therapy only
Trial: 16154196
Drug: Intravitreous pegaptanib
RxNorm normalized name: pegaptanib
DrugBank: Pegaptanib (DB04895)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravitreous pegaptanib (0.3 mg)
Trial: 12190957
Drug: TUDCA (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TUDCA (1000 mg)
Trial: 12190957
Drug: UDCA (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA (750 mg)
Trial: 7561189
Drug: Liposome-adjuvanted vaccine
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposome-adjuvanted vaccine
Trial: 7561189
Drug: Control subvirion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control subvirion vaccine
Trial: 647263
Drug: Symptomatic diagnosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptomatic diagnosis and medications
Trial: 647263
Drug: No evidence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No evidence of disease and no treatment
Trial: 27215528
Drug: Partial stapled
RxNorm normalized name: rosin partially dimerized glycerol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partial stapled transanal rectal resection (part‐STARR) combined with Bresler procedure
Trial: 20843951
Drug: Tamoxifen (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (10 and 20 mg/d)
Trial: 20843951
Drug: Raloxifene (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (60 and 120 mg/d)
Trial: 6397516
Drug: Prostaglandin synthesis
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostaglandin synthesis inhibition by indomethacin (150 mg daily for three days plus an additional 50 mg on the morning of the active experiments)
Trial: 26572899
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg (1 capsule 1 hour before surgery and 1 placebo capsule every 8 hours for 2 days)
Trial: 26572899
Drug: Ketorolac 10
RxNorm normalized name: ketorolac 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 10 mg (1 capsule 1 hour before surgery and every 8 hours for 2 days)
Trial: 25247991
Drug: 12-month maintenance
RxNorm normalized name: cenobamate
DrugBank: Cenobamate (DB06119)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 12-month maintenance program consisting of one monthly supervised high intensity interval training session, a written exercise program and exercise diary, and a maximum exercise test every third month during follow-up.
Trial: 20103758
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy with hydrocortisone
Trial: 20103758
Drug: Conventional insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional insulin therapy with hydrocortisone
Trial: 20103758
Drug: Fludrocortisone with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludrocortisone with intensive insulin therapy
Trial: 20103758
Drug: Fludrocortisone with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludrocortisone with conventional insulin therapy
Trial: 18049323
Drug: Educational interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Educational interventions for siblings of hospitalized children, conducted by child life specialists, focusing on hospitalization, illness or injury, and treatment.
Trial: 9509976
Drug: G‐CSF (Filgrastim)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF (Filgrastim) 5 microg/kg/day starting on day +1 until ANC > 500/microl
Trial: 20673585
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no G‐CSF)
Trial: 7541660
Drug: G‐CSF (Filgrastim)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF (Filgrastim)
Trial: 8092777
Drug: Vaginal prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal prostaglandin E2 gel (1 mg of dinoprostone/2.5 ml gel)
Trial: 8092777
Drug: Intracervical prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical prostaglandin E2 gel (0.5 mg of dinoprostone in 2.5 ml of two different vehicles)
Trial: 8092777
Drug: Prostaglandin gel
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostaglandin gel alone
Trial: 3402178
Drug: Heparin sodium
RxNorm normalized name: Heparin Sodium
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin sodium 100 units/mL flush solution
Trial: 3402178
Drug: 0.9% sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% sodium chloride flush solution
Trial: 30142141
Drug: Initiation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initiation of Antiretroviral Therapy (ART)
Trial: 24691032
Drug: BFR exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BFR exercise with rapamycin (RAP) 16 mg administered 1 h prior to exercise
Trial: 22111758
Drug: 4.8 mm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.8 mm diameter implants (test group)
Trial: 22111758
Drug: 4.3 mm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.3 mm diameter implants (control group)
Trial: 19809412
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg twice daily (group A)
Trial: 19809412
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg once daily (group B)
Trial: 19809412
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg every other day (group C)
Trial: 18265809
Drug: Chemotherapy (specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (specific drugs not mentioned)
Trial: 18265809
Drug: Cisplatin (dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (dosage not specified)
Trial: 18265809
Drug: Salvage chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salvage chemotherapy (specific drugs not mentioned)
Trial: 18265809
Drug: Chemotherapy for
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy for patients with brain metastases
Trial: 18265809
Drug: Specific drugs
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific drugs for patients with bone metastases